FDA Inspection 1134544 — ADC Therapeutics, SA
The FDA completed an inspection of ADC Therapeutics, SA on Dec 22, 2020 in New Providence, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 22, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- New Providence, NJ (United States)
Additional Details
Sponsor, Contract Research Organization